MARKET

CERT

CERT

Certara, Inc.
NASDAQ
8.52
+0.10
+1.19%
Pre Market: 8.55 +0.03 +0.35% 04:00 09/22 EDT
OPEN
8.49
PREV CLOSE
8.42
HIGH
8.64
LOW
8.43
VOLUME
1
TURNOVER
0
52 WEEK HIGH
13.88
52 WEEK LOW
4.450
MARKET CAP
1.30B
P/E (TTM)
-19.3153
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERT last week (0914-0918)?
Weekly Report · 1d ago
Certara: Hold Rating Reiterated as Transition Risks Offset Long-Term Biosimulation and AI Upside; $9 Price Target Maintained
TipRanks · 5d ago
Certara Stock Is Up 5.0% What's Changed After Software Growth And Job Cuts
Simply Wall St · 5d ago
Weekly Report: what happened at CERT last week (0907-0911)?
Weekly Report · 09/14 10:09
Certara (CERT) Software Growth Meets Restructuring Costs, Is The Stock Still A Bargain?
Simply Wall St · 09/14 08:12
Weekly Report: what happened at CERT last week (0831-0904)?
Weekly Report · 09/07 10:03
Weekly Report: what happened at CERT last week (0824-0828)?
Weekly Report · 08/31 10:10
HHS said to be eyeing two new FDA deputy commissioners for technology and drugs
Seeking Alpha · 08/25 17:53
More
About CERT
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.